Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1688 of 5804
-
Can a weekly drug combo outsmart resistant lymphoma?
Disease control OngoingThis phase II pilot trial studies how well brentuximab vedotin with or without nivolumab works in treating patients with CD30+ lymphoma that has come back after a period of improvement or does not respond to treatment. Biological therapies, such as brentuximab vedotin, may stimul…
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Arthritis drug tofacitinib tested for Long-Term safety in kids
Disease control CompletedEvaluate long-term safety and tolerability of tofacitinib in patients with JIA, who have previously participated in tofacitinib JIA studies.
Phase: PHASE2, PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could a One-Hour shock boost nerve repair after severe arm injury?
Disease control CompletedThe primary goal of this study is to quantify the functional deficits caused by injuries to the brachial plexus and peripheral nerve in the arm. The second goal is to test the possible benefit of electrical stimulation of the injured nerve following surgery. The investigators wil…
Phase: NA • Sponsor: University of Alberta • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Arm muscle may replace liver for insulin cell transplants
Disease control OngoingThe liver may not be an optimal site for islet transplantation due to obstacles by an instant blood-mediated inflammatory response, and low revascularization of transplanted islets. Therefore, intramuscular islet transplantation offers an attractive alternative, based on its simp…
Phase: PHASE1, PHASE2 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New combo therapy shows promise for Hard-to-Treat cancers
Disease control CompletedThis phase I trial studies the side effects and best dose of vemurafenib when given together with cetuximab and irinotecan hydrochloride in treating patients with solid tumors that have spread to other parts of the body or cannot be removed by surgery. Vemurafenib and irinotecan …
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Lung cancer drug combo tested in Mid-Stage trial
Disease control OngoingThis randomized phase II trial studies how well giving erlotinib hydrochloride and cabozantinib-s-malate alone or in combination works as second or third line therapy in treating patient with stage IV non-small cell lung cancer. Erlotinib hydrochloride and cabozantinib-s-malate m…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New hope for kids with neuroblastoma: experimental combo enters human testing
Disease control OngoingThis phase I trial studies the side effects and best dose of lenalidomide when given together with dinutuximab with or without isotretinoin in treating younger patients with neuroblastoma that does not respond to treatment or that has come back. Drugs used in chemotherapy, such a…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Bladder cancer battle: which chemo regimen wins before or after surgery?
Disease control CompletedRadical cystectomy remains the gold standard treatment for invasive non metastatic transitional cell cancer (TCC) of the bladder. In contemporary series, specific survival rates are about 60 to 65% at 5 years, decreasing for locally advanced disease to 45-50% in patients with non…
Phase: PHASE3 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Mild electric current may deliver bowel medication through skin, no needles needed
Disease control CompletedBowel care (BC) is a time-consuming and cumbersome activity of daily living for most individuals with SCI. Previous studies have reported that the average time to complete a BC routine is 45 minutes; 10-20% of SCI individuals report BC routines lasting for more than 1 hour. In pa…
Phase: EARLY_PHASE1 • Sponsor: James J. Peters Veterans Affairs Medical Center • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New scope test could sharpen lung cancer staging, spare patients unnecessary radiation
Diagnosis Recruiting nowIt is reported that more than 90,000 patients died of lung cancer and more than 20% of them were older than 80 years in North America. Therefore a less invasive but effective treatment is required for patients with lung cancer of advanced age, diminished pulmonary functions, and …
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
New laser device could catch spreading melanoma cells in real time
Diagnosis Recruiting nowThe objective of this clinical trial is to determine whether a Photoacoustic flow cytometry (PAFC)-based prototype device can detect circulating tumor cells (CTCs) in the blood of melanoma patients in vivo, in real time, and do so at detection limits at least one order of magnitu…
Sponsor: University of Arkansas • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
New immune cells take aim at Virus-Linked lymphomas
Disease control Recruiting nowSubjects have a type of lymph gland disease called Hodgkin or non-Hodgkin Lymphoma or T/NK-lymphoproliferative disease or severe chronic active Epstein Barr Virus (CAEBV) which has come back, is at risk of coming back, or has not gone away after treatment, including the best trea…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Could a chemo combo save lungs in scleroderma patients?
Disease control CompletedBy including in this study patients with significant worsening of their lung volumes and / or their DLCO (carbon monoxide diffusing capacity) in the previous year, on the basis of an open retrospective study we recently conducted, we hope to demonstrate that a strategy combining …
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 26, 2026 16:08 UTC
-
New balloon treatment may replace surgery for early esophageal cancer
Disease control CompletedFirst intent treatment for superficial circular esophageal neoplasm is surgical resection. Endoscopic mucosal resection is not recommended due to the high rate of subsequent esophageal stenosis (higher than 80%). Surgical limits are related to a high level of morbidity due, in p…
Phase: PHASE4 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
When is the best time to exercise during breast cancer treatment?
Symptom relief OngoingThe purpose of this study is to compare the effects of aerobic exercise training during and after chemotherapy for women who have recently been diagnosed with early-stage breast cancer. The participant will be instructed to self-report the session information to ExOnc staff at o…
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
Blood scores may identify low-risk patients after hepatitis c cure, reducing need for lifelong cancer scans
Knowledge-focused CompletedThis retrospective cohort study evaluated the performance of non-invasive risk scores for predicting de novo hepatocellular carcinoma in adults with hepatitis C virus-related compensated advanced chronic liver disease who achieved sustained virological response after sofosbuvir-b…
Sponsor: Siriraj Hospital • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
Could a Child's own cord blood stem cells restore hearing?
Disease control CompletedTo determine if autologous human umbilical cord blood infusion in children with acquired hearing loss is safe, feasible, improves inner ear function, audition and language development.
Phase: PHASE1 • Sponsor: James Baumgartner, MD • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New hope for GVHD patients: nilotinib steps in when imatinib fails
Disease control CompletedOpen label non-randomized multicenter phase 2 trial with direct individual benefice
Phase: PHASE2 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Balloon breakthrough: No-Stent fix for clogged heart arteries shows promise
Disease control CompletedThe CTO-DENOVO study is a multicenter registry of consecutive patients with de novo coronary chronic total occlusions (CTO) undergoing successful CTO recanalization with the use of drug-coated balloon (DCB)-only strategy. The primary endpoint is target lesion failure at 6 months.…
Sponsor: National Institute of Cardiology, Warsaw, Poland • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Can freezing tumors control prostate cancer recurrence?
Disease control OngoingThe purpose of this research is to see if MR-guided cryoablation can effectively treat prostate tumor recurrences.
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 26, 2026 13:59 UTC